BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kriz D, Ansari D, Andersson R. Potential biomarkers for early detection of pancreatic ductal adenocarcinoma. Clin Transl Oncol. 2020;22:2170-2174. [PMID: 32447642 DOI: 10.1007/s12094-020-02372-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 DeLouize AM, Eick G, Karam SD, Snodgrass JJ. Current and future applications of biomarkers in samples collected through minimally invasive methods for cancer medicine and population-based research. Am J Hum Biol 2021;:e23665. [PMID: 34374148 DOI: 10.1002/ajhb.23665] [Reference Citation Analysis]
2 Lin KW, Ang TL, Li JW. Role of artificial intelligence in early detection and screening for pancreatic adenocarcinoma. Artif Intell Med Imaging 2022; 3(2): 21-32 [DOI: 10.35711/aimi.v3.i2.21] [Reference Citation Analysis]
3 Ren Q, Wang J, Liu C, Meng LX, Qian RK, Gao HJ, Qin W, Zhou CJ, Qiao S, Wang HY, Zhang LT, Zhang YT. Exploring the sulfate patterns of chondroitin sulfate/dermatan sulfate and keratan sulfate in human pancreatic cancer. J Pharm Biomed Anal 2021;205:114339. [PMID: 34464868 DOI: 10.1016/j.jpba.2021.114339] [Reference Citation Analysis]
4 O'Neill RS, Stoita A. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket? World J Gastroenterol 2021; 27(26): 4045-4087 [PMID: 34326612 DOI: 10.3748/wjg.v27.i26.4045] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]